Don't miss out on the latest news, evidence and CPD opportunities on medicines and medical tests - sign up today.
You have not selected any filters.
NPS RADAR provides health professionals with timely, independent evidence-based information on new drugs and medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.
From 1 March 2016 several new direct-acting antiviral regimens became available on the PBS in a major advance in chronic HCV therapy
Now PBS listed as a first-line, interferon-free treatment option for chronic HCV genotype 1
Now PBS listed as a first-line interferon-free combination treatment option for chronic HCV genotypes 1 and 3